NGM BIOPHARMACEUTICALS INC: common_shares_outstanding
| Value | {"unit": "shares", "value": 81726113, "concept": "dei:EntityCommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2022-10-31) |
| Status | current |
| Entity | NGM BIOPHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:00:56.671043+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ffc3f879-e46e-41a7-b90e-6fcdc829d50e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-22-028215 · Open the official SEC filing →Retrieved: 2026-08-19T14:00:56.671043+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001426332/common-shares-outstanding/2022-10-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ffc3f879-e46e-41a7-b90e-6fcdc829d50e
History
- no predecessors — first report